- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Madrigal Pharmaceuticals
Market Cap: US$12.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$529.14
7D
2.0%
1Y
71.4%
Insmed
Market Cap: US$30.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$144.48
7D
-1.5%
1Y
104.1%
Ionis Pharmaceuticals
Market Cap: US$12.4b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$74.83
7D
-2.6%
1Y
157.1%
Alnylam Pharmaceuticals
Market Cap: US$40.9b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$310.58
7D
-6.8%
1Y
28.4%
Ascendis Pharma
Market Cap: US$14.8b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$231.05
7D
n/a
1Y
n/a
BeOne Medicines
Market Cap: US$34.6b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$312.41
7D
-2.4%
1Y
25.4%
BridgeBio Pharma
Market Cap: US$14.8b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$74.44
7D
-4.2%
1Y
111.3%
AbbVie
Market Cap: US$362.8b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$200.50
7D
-3.8%
1Y
13.2%
Jazz Pharmaceuticals
Market Cap: US$12.3b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$202.40
7D
1.5%
1Y
94.3%
Eli Lilly
Market Cap: US$808.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$921.48
7D
1.8%
1Y
11.1%
Natera
Market Cap: US$29.1b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$207.78
7D
0.3%
1Y
39.9%
Royalty Pharma
Market Cap: US$29.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$49.72
7D
2.1%
1Y
56.9%
Viatris
Market Cap: US$17.2b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$14.52
7D
4.8%
1Y
85.9%
Elanco Animal Health
Market Cap: US$11.3b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.46
7D
-3.3%
1Y
144.4%
Revvity
Market Cap: US$10.5b
Provides health sciences solutions, technologies, and services.
RVTY
US$94.28
7D
1.5%
1Y
0.6%
BioMarin Pharmaceutical
Market Cap: US$10.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.15
7D
-2.0%
1Y
-12.6%
Waters
Market Cap: US$32.9b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$334.38
7D
2.5%
1Y
-0.1%